Controversial Alzheimer’s Drug Trial Stopped Due to Disappointing Outcome

0
ss5_p-200128962pv-1u-ngfpllsf3kjnibxllynev-repyrgdzccl4n1q5qu9g-1

Cassava Sciences reported that their medication did not show a significant reduction in cognitive decline among 1,900 individuals with mild to moderate Alzheimer’s disease.

Leave a Reply

Your email address will not be published. Required fields are marked *